-+ 0.00%
-+ 0.00%
-+ 0.00%

Insight Molecular Diagnostics: Q2 Earnings Snapshot

Barchart·08/10/2026 15:39:53
Listen to the news

NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $11.3 million in its second quarter.

The Nashville, Tennessee-based company said it had a loss of 31 cents per share. Losses, adjusted for non-recurring costs, came to 23 cents per share.

The cancer diagnostic test developer posted revenue of $239,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDX